SMN Dosage Analysis and Risk Assessment for Spinal Muscular Atrophy
AUTOR(ES)
Ogino, Shuji
FONTE
The American Society of Human Genetics
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=379149Documentos Relacionados
- A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy
- Lentivector-mediated SMN replacement in a mouse model of spinal muscular atrophy
- Coilin forms the bridge between Cajal bodies and SMN, the Spinal Muscular Atrophy protein
- Diagnosis of spinal muscular atrophy in an SMN non-deletion patient using a quantitative PCR screen and mutation analysis.
- SMN mutants of spinal muscular atrophy patients are defective in binding to snRNP proteins